Pseudoephedrine – Risks of PRES and RCVS
09/02/2024
Medicines for human use
Direct healthcare professional communication (DHPC)
Pseudoephedrine – Risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)